Genetic variation in the TP53 pathway and bladder cancer risk. A comprehensive analysis

PLoS ONE

Volumn 9, Issue 5, 2014, Pages

  Pineda, Silvia ^a   Milne, Roger L ^a   Calle, M Luz ^b   Rothman, Nathaniel ^c   López De Maturana, Evangelina ^a   Herranz, Jesús ^a   Kogevinas, Manolis ^d,e   Chanock, Stephen J ^c   Tardón, Adonina ^f   Márquez, Mirari ^a   Guey, Lin T ^a   García Closas, Montserrat ^c   Lloreta, Josep ^e,g   Baum, Erin ^a   González Neira, Anna ^a   Carrato, Alfredo ^h,i   Navarro, Arcadi ^j,k,l,m   Silverman, Debra T ^c   Real, Francisco X ^a,j   Malats, Núria ^a  

^a Centro Nacional de Investigaciones Oncológicas   (Spain)

^b UNIVERSITY OF VIC CENTRAL UNIVERSITY OF CATALONIA   (Spain)

^c NATIONAL CANCER INSTITUTE   (United States)

^d CENTRE FOR RESEARCH IN ENVIRONMENTAL EPIDEMIOLOGY CREAL   (Spain)

^e INST MUNIC D INVESTIGACIO MEDICA   (Spain)

^f UNIVERSITY OF OVIEDO   (Spain)

^g HOSPITAL DEL MAR   (Spain)

^h HOSPITAL GENERAL UNIVERSITARIO DE ELCHE   (Spain)

ⁱ HOSPITAL RAMÓN Y CAJAL   (Spain)

^j UNIVERSITAT POMPEU FABRA   (Spain)

^k INSTITUTE OF EVOLUTIONARY BIOLOGY CSIC UNIVERSITAT POMPEU FABRA   (Spain)

^l INSTITUCIÓ CATALANA DE RECERCA I ESTUDIS AVANÇATS ICREA   (Spain)

^m Instituto Nacional de Bioinformatica   (Spain)

more..

Author keywords

[No Author keywords available]

Indexed keywords

DNA; PROTEIN BAK; PROTEIN P53; SOMATOMEDIN C RECEPTOR;

ADULT; AGED; ARTICLE; BAK1 GENE; BLADDER CANCER; BLOOD ANALYSIS; CANCER GRADING; CANCER RISK; CANCER STAGING; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; GERM LINE; HUMAN; IGF1R GENE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; P53AIP1 GENE; PMAIP1 GENE; RISK ASSESSMENT; SERINPB5 GENE; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; TP53 GENE; TP63 GENE; TP73 GENE; TUMOR GENE; YOUNG ADULT; BLADDER TUMOR; GENETIC PREDISPOSITION; GENETICS; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; GENOTYPE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; TUMOR SUPPRESSOR PROTEIN P53; URINARY BLADDER NEOPLASMS; YOUNG ADULT;

EID: 84901275033     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0089952     Document Type: Article

References (36)

1. Ferlay JSH, Bray F, Forman D, Mathers C, Parkin DM (2010) GLOBOCAN 2008 v1.2, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 10. Lyon, France: International Agency for Research on Cancer.
2. Samanic C, Kogevinas M, Dosemeci M, Malats N, Real FX, et al. (2006) Smoking and bladder cancer in Spain: effects of tobacco type, timing, environmental tobacco smoke, and gender. Cancer Epidemiol Biomarkers Prev 15: 1348-1354. (Pubitemid 44125293)
3. Malats N (2008) Genetic epidemiology of bladder cancer: scaling up in the identification of low-penetrance genetic markers of bladder cancer risk and progression. Scand J Urol Nephrol Suppl: 131-140.
4. Rothman N, Garcia-Closas M, Chatterjee N, Malats N, Wu X, et al. (2010) A multi-stage genome-wide association study of bladder cancer identifies multiple susceptibility loci. Nat Genet 42: 978-984.
5. Luis NM, Lopez-Knowles E, Real FX (2007) Molecular biology of bladder cancer. Clin Transl Oncol 9: 5-12.
6. Wu XR (2005) Urothelial tumorigenesis: a tale of divergent pathways. Nat Rev Cancer 5: 713-725.
7. Guey LT, Garcia-Closas M, Murta-Nascimento C, Lloreta J, Palencia L, et al. (2010) Genetic susceptibility to distinct bladder cancer subphenotypes. Eur Urol 57: 283-292.
8. Real FX, Malats N (2007) Bladder cancer and apoptosis: matters of life and death. Lancet Oncol 8: 91-92. (Pubitemid 46158377)
9. Mitra AP, Hansel DE, Cote RJ (2012) Prognostic value of cell-cycle regulation biomarkers in bladder cancer. Semin Oncol 39: 524-533.
10. Malkin D, Friend SH, Li FP, Strong LC (1997) Germ-line mutations of the p53 tumor-suppressor gene in children and young adults with second malignant neoplasms. N Engl J Med 336: 734.
11. Malkin D, Li FP, Strong LC, Fraumeni JF Jr, Nelson CE, et al. (1990) Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science 250: 1233-1238. (Pubitemid 120031831)
12. Whibley C, Pharoah PD, Hollstein M (2009) p53 polymorphisms: cancer implications. Nat Rev Cancer 9: 95-107.
13. Jiang DK, Ren WH, Yao L, Wang WZ, Peng B, et al. (2010) Meta-analysis of association between TP53 Arg72Pro polymorphism and bladder cancer risk. Urology 76: 765 e761-767.
14. Klug SJ, Ressing M, Koenig J, Abba MC, Agorastos T, et al. (2009) TP53 codon 72 polymorphism and cervical cancer: a pooled analysis of individual data from 49 studies. Lancet Oncol 10: 772-784.
15. Liu KJ, Qi HZ, Yao HL, Lei SL, Lei ZD, et al. (2012) An updated meta-analysis of the p53 codon 72 polymorphism and gastric cancer risk. Mol Biol Rep 39: 8265-8275.
16. Qiao Q, Hu W (2013) The Association Between TP53 Arg72Pro Polymorphism and Lung Cancer Susceptibility: Evidence from 30,038 Subjects. Lung 191: 369-377.
17. Yang ZNS, Zhu H, Wu X, Jia S, Luo Y, et al. (2013) Association of p53 Arg72Pro polymorphism with bladder cancer: a meta-analysis. Gene 512: 408-413.
18. Zhang Z, Wang M, Wu D, Tong N, Tian Y (2009) P53 codon 72 polymorphism contributes to breast cancer risk: a meta-analysis based on 39 case-control studies. Breast Cancer Res Treat 120: 509-517.
19. Epstein JI, Amin MB, Reuter VR, Mostofi FK (1998) The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder Consensus Conference Committee. Am J Surg Pathol 22: 1435-1448. (Pubitemid 28550639)
20. Lorente-Galdos B, Medina I, Morcillo-Suarez C, Heredia T, Carreno-Torres A, et al. (2012) Select your SNPs (SYSNPs): a web tool for automatic and massive selection of SNPs. Int J Data Min Bioinform 6: 324-334.
21. Browning SR, Browning BL (2007) Rapid and accurate haplotype phasing and missing-data inference for whole-genome association studies by use of localized haplotype clustering. Am J Hum Genet 81: 1084-1097. (Pubitemid 47580259)
22. Tibshirani R (1996) Regression Shrinkage and Selection via the Lasso. Journal of the Royal Statistical Society Series B (Methodological) 58: 267-288.
23. Friedman J, Hastie T, Thibshirani R (2001) The Elements of statistical learning: Data mining, inference and prediction. Springer Series in Statistics 533 214-216.
24. Efron B (1979) Bootstrap Methods: Another Look at the Jackknife. Annals of Statistics 7: 1-26.
25. Goeman JJ (2010) L1 penalized estimation in the Cox proportional hazards model. Biom J 52: 70-84.
26. Zhou Y, Li N, Zhuang W, Liu GJ, Wu TX, et al. (2007) P53 codon 72 polymorphism and gastric cancer: a meta-analysis of the literature. Int J Cancer 121: 1481-1486. (Pubitemid 47328706)
27. Yan L, Zhang D, Chen C, Mao Y, Xie Y, et al. (2009) TP53 Arg72Pro polymorphism and lung cancer risk: a meta-analysis. Int J Cancer 125: 2903-2911.
28. Naccarati A, Polakova V, Pardini B, Vodickova L, Hemminki K, et al. (2012) Mutations and polymorphisms in TP53 gene-an overview on the role in colorectal cancer. Mutagenesis 27: 211-218.
29. Lin HY, Yang MC, Huang CH, Wu WJ, Yu TJ, et al. (2013) Polymorphisms of TP53 are markers of bladder cancer vulnerability and prognosis. Urol Oncol 31: 1231-1241.
30. Kiemeney LA, Thorlacius S, Sulem P, Geller F, Aben KK, et al. (2008) Sequence variant on 8q24 confers susceptibility to urinary bladder cancer. Nat Genet 40: 1307-1312.
31. Lichtenstein P, Holm NV, Verkasalo PK, Iliadou A, Kaprio J, et al. (2000) Environmental and heritable factors in the causation of cancer-analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med 343: 78-85. (Pubitemid 30451850)
32. Gibson G (2011) Rare and common variants: twenty arguments. Nat Rev Genet 13: 135-145.
33. Hoh J, Ott J (2003) Mathematical multi-locus approaches to localizing complex human trait genes. Nat Rev Genet 4: 701-709. (Pubitemid 37046137)
34. Wu TT, Chen YF, Hastie T, Sobel E, Lange K (2009) Genome-wide association analysis by lasso penalized logistic regression. Bioinformatics 25: 714-721.
35. Zhou H, Sehl ME, Sinsheimer JS, Lange K (2010) Association screening of common and rare genetic variants by penalized regression. Bioinformatics 26: 2375-2382.
36. Louhelainen JP, Hurst CD, Pitt E, Nishiyama H, Pickett HA, et al. (2006) DBC1 re-expression alters the expression of multiple components of the plasminogen pathway. Oncogene 25: 2409-2419.